Company Introduction

TBG Biotechnology Corp. (TBG) is a global molecular diagnostics company dedicated to the development, manufacture and marketing of molecular diagnostics kits, instruments and services. With its research and development based in the US, Taiwan and China, TBG manufactures its products in its ISO13485 certified facilities in Taiwan and China serving the clinical labs of both hospitals and independent reference labs, blood centers and bone marrow registry labs around the world.

Brief description of main products or services 

• TBG Biotechnology Corp. is currently producing In Vitro Diagnostics (IVD) reagents and equipment for immunogenetics and infectious diseases.  Our immunogenetic testing reagents include genotyping assay for Human Leukocyte Antigen (HLA), Human Platelet Antigen (HPA), and Killer Immunoglobulin Receptor (KIR).  Our latest infectious disease reagents include assay for the detection SARS-CoV-2 virus. In order to provide a total solution, TBG produces sample extraction/preparation systems, automated pipetting systems, and real time PCR analysis system. Our reagents and equipment are produced under ISO13485 and registered with multiple regulatory environments including CE-IVD, Taiwan FDA, and US FDA. TBG also established reference laboratories that offers genetic testing services in Taiwan and China.